Skip to main content

Advertisement

SpringerLink
Log in

Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget’s disease of bone

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Scanty data about glucose metabolism and hypertension have been reported in Paget’s disease of bone (PDB) to be related with increased cardiovascular mortality. The aim of the present study was to evaluate glucose and blood pressure levels in PDB, looking for their association with disease severity.

Methods

We performed an observational cross-sectional study in 54 patients with PDB and 54 age, sex and BMI-matched controls. Glucose and blood pressure levels and parameters of bone and mineral metabolism were assessed.

Results

Patients with PDB showed increased glucose levels (6.3 ± 1.7 vs 5.3 ± 1.4 mmol/l, p < 0.001) and prevalence of impaired fasting glucose (14.8%, 5.3–24.3 vs 1.9%, 0–5.4, p < 0.02) as well as enhanced systolic blood pressure (145.9 ± 21.3 vs 132.9 ± 18.9 mmHg, p < 0.005), pulse pressure (69.6 ± 20.0 vs 56.0 ± 16.9 mmHg, p < 0.01) and prevalence of isolated systolic hypertension (46.3%, 33.0–59.6 vs 16.7%, 6.7–26.6, p < 0.003) in comparison to controls. Moreover, we found a positive association of (1) glucose levels with ionized calcium and bone alkaline phosphatase; (2) both systolic and pulse pressure with total and bone alkaline phosphatase (p < 0.05). By multiple linear regression analysis (R2 = 0.26; p < 0.05) serum ionized calcium correlated with glucose levels (β = 0.44; p < 0.04), after adjusting for age and BMI.

Conclusions

Our study shows increased fasting glucose, systolic and pulse pressure levels as well as enhanced prevalence of impaired fasting glucose and isolated systolic hypertension in PDB, potentially accounting for increased cardiovascular mortality. Furthermore, our findings suggest high serum calcium and/or increased bone alkaline phosphatase as a link between PDB and cardio-metabolic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S.H. Ralston, Clinical practice. Paget’s disease of bone. N. Engl. J. Med. 368(7), 644–50 (2013)

    Article  CAS  PubMed  Google Scholar 

  2. R.C. Moehlig, H.L. Abbott, Carbohydrate metabolism in osteitis deformans, or Paget’s disease. J. Am. Med. Assoc. 134(18), 1521–4 (1947)

    Article  CAS  PubMed  Google Scholar 

  3. N.G. Schneeberg, Observations on the glucose tolerance test in Paget’s disease (osteitis deformans). Am. J. Med. Sci. 219(6), 664–73 (1950)

    Article  CAS  PubMed  Google Scholar 

  4. C.F. Sornberger, M.I. Smedal, The mechanism and incidence of cardiovascular changes in Paget’s disease (osteitis deformans); a critical review of the literature with case studies. Circulation 6(5), 711–26 (1952)

    Article  CAS  PubMed  Google Scholar 

  5. T.P. Van Staa, P. Selby, H.G.M. Leufkens, K. Lyles, J.M. Sprafka, C. Cooper, Incidence and natural history of Paget’s disease of bone in England and Wales. J. Bone Miner. Res. 17(3), 465–71 (2002)

    Article  PubMed  Google Scholar 

  6. E.S. Siris, Epidemiological aspects of Paget’s disease: family history and relationship to other medical conditions. Semin. Arthritis Rheum. 23(4), 222–5 (1994)

    Article  CAS  PubMed  Google Scholar 

  7. R.A. Wermers, R.D. Tiegs, E.J. Atkinson, S.J. Achenbach, L.J. Melton, Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J. Bone Miner. Res. 23(6), 819–25 (2008)

    Article  PubMed  PubMed Central  Google Scholar 

  8. T.A.P. Fernandes, L.M.L. Gonçalves, J.A.A. Brito, Relationships between bone turnover and energy metabolism. J. Diabetes Res. 2017, 9021314 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. M. Ghodsi, B. Larijani, A.A. Keshtkar, E. Nasli-Esfahani, S. Alatab, M.R. Mohajeri-Tehrani, Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J. Diabetes Metab. Disord. 15, 52 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. C.L. Cheung, K.C.B. Tan, K.S.L. Lam, B.M.Y. Cheung, The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J. Clin. Endocrinol. Metab. 98(9), 3856–63 (2013)

    Article  CAS  PubMed  Google Scholar 

  11. M. Procopio, M. Barale, S. Bertaina, S. Sigrist, R. Mazzetti, M. Loiacono, G. Mengozzi, E. Ghigo, M. Maccario, Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine 47(2), 581–9 (2014)

    Article  CAS  PubMed  Google Scholar 

  12. E. Kamycheva, R. Jorde, Y. Figenschau, E. Haug, Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J. Endocrinol. Invest. 30(2), 126–32 (2007)

    Article  CAS  PubMed  Google Scholar 

  13. World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation (2006), http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/. Accessed 12 Apr 2018

  14. G. Mancia, 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood. Press. 23(1), 3–16 (2014)

    Article  PubMed  Google Scholar 

  15. R. Luboshitzky, Y. Chertok-Schaham, I. Lavi, A. Ishay, Cardiovascular risk factors in primary hyperparathyroidism. J. Endocrinol. Invest. 32(4), 317–21 (2009)

    Article  CAS  PubMed  Google Scholar 

  16. N.J. Wareham, C.D. Byrne, C. Carr, N.E. Day, B.J. Boucher, C.N. Hales, Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46(10), 1171–7 (1997)

    Article  CAS  PubMed  Google Scholar 

  17. K.A. Toulis, K. Nirantharakumar, R. Ryan, T. Marshall, K. Hemming, Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study. J. Clin. Endocrinol. Metab. 100(5), 1933–40 (2015)

    Article  CAS  PubMed  Google Scholar 

  18. P. Tangseefa, S.K. Martin, S. Fitter, P.A. Baldock, C.G. Proud, A.C.W. Zannettino, Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance. J. Cell. Physiol. 233(5), 3769–83 (2018)

    Article  CAS  PubMed  Google Scholar 

  19. S. Shankar, D.J. Hosking, Biochemical assessment of Paget’s disease of bone. J. Bone Miner. Res. 21(Suppl 2), P22–27 (2006)

    Article  CAS  PubMed  Google Scholar 

  20. B. Merle, P.D. Delmas, Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget’s disease of bone. Bone Miner. 11(2), 237–45 (1990)

    Article  CAS  PubMed  Google Scholar 

  21. C. Letizia, P. Ferrari, D. Cotesta, C. Caliumi, R. Cianci, S. Cerci, L. Petramala, M. Celi, S. Minisola, E. D’Erasmo, G.F. Mazzuoli, Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J. Hum. Hypertens. 19(11), 901–6 (2005)

    Article  CAS  PubMed  Google Scholar 

  22. A. Pujia, C. Gazzaruso, T. Montalcini, An update on the potential role of C-peptide in diabetes and osteoporosis. Endocrine 58(3), 408–12 (2017)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General and Specialty Medicine, Division of Endocrinology, Diabetology and Metabolic Diseases, Molinette Hospital, University of Turin—Cso Dogliotti, Turin, 14-10126, Italy

    Marco Barale, Vincenzo Cappiello, Ezio Ghigo & Massimo Procopio

Authors
  1. Marco Barale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincenzo Cappiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ezio Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Procopio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Barale.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Due to the retrospective design of the study, formal informed consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barale, M., Cappiello, V., Ghigo, E. et al. Increased frequency of impaired fasting glucose and isolated systolic hypertension in Paget’s disease of bone. Endocrine 63, 385–390 (2019). https://doi.org/10.1007/s12020-018-1771-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1771-5

Keywords

Search

Navigation